Advertisement
Research ArticleArticle

Spinal opioid tolerance depends upon platelet-derived growth factor receptor-β signaling, not mu-opioid receptor internalization

Stephanie Puig, Katherine E Barker, Shelby R Szott, Peter T Kann, Jeffrey S Morris and Howard B Gutstein
Molecular Pharmacology July 28, 2020, mol.120.119552; DOI: https://doi.org/10.1124/mol.120.119552

Article Information

mol.120.119552
DOI 
https://doi.org/10.1124/mol.120.119552
PubMed 
32723769
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online July 28, 2020.

Article Versions

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Stephanie Puig1,
  2. Katherine E Barker2,
  3. Shelby R Szott1,
  4. Peter T Kann1,
  5. Jeffrey S Morris3, and
  6. Howard B Gutstein4,*
  1. 1 University of Pittsburgh;
  2. 2 MD Anderson Cancer Center;
  3. 3 University of Pennsylvania;
  4. 4 Allegheny Health Network
  1. ↵*Address correspondence to: gutsteinh{at}gmail.com

Statistics from Altmetric.com

Article usage

Article usage: July 2020 to January 2021

AbstractFullPdf
Jul 2020129017
Aug 2020276051
Sep 2020734737
Oct 20202726055
Nov 202073319
Dec 2020103320
Jan 20213658

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Research ArticleArticle

Spinal opioid tolerance depends upon platelet-derived growth factor receptor-β signaling, not mu-opioid receptor internalization

Stephanie Puig, Katherine E Barker, Shelby R Szott, Peter T Kann, Jeffrey S Morris and Howard B Gutstein
Molecular Pharmacology July 28, 2020, mol.120.119552; DOI: https://doi.org/10.1124/mol.120.119552
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section